Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Cell Reports. Medicine|January 18, 2023
Proteome-based insights for IDH-mutant glioma classificationSeverina Leu, Gregor Hutter, Jean-Louis BoulayJournal of Proteome Research|June 16, 2025
Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype GlioblastomaMichèle Amer Salem, Jean-Louis Boulay, Marie-Françoise Ritz, et al.Journal of Neuro-Oncology|January 19, 2016
IDH mutation is associated with higher risk of malignant transformation in low-grade gliomaSeverina Leu, Stefanie von Felten, Stephan Frank, et al.Neuro-Oncology|February 15, 2013
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survivalSeverina Leu, Stefanie von Felten, Stephan Frank, et al.World Neurosurgery|April 22, 2018
Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient SurvivalSeverina Leu, Jean-Louis Boulay, Sarah Thommen, et al.Frontiers in Immunology|October 29, 2020
Microglia-Centered Combinatorial Strategies Against GlioblastomaTomás A Martins, Philip Schmassmann, Tala Shekarian, et al.Ebiomedicine|July 24, 2019
Quantitative proteomics reveals reduction of endocytic machinery components in gliomasDominik P Buser, Marie-Françoise Ritz, Suzette Moes, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|October 9, 2014
Langer-Giedion syndrome associated with congenital dural arterio-venous fistulaSeverina Leu, Anton Valavanis, Gerasimos BaltsaviasBMC Medicine|November 17, 2010
Notch signaling in glioblastoma: a developmental drug target?Maria Maddalena Lino, Adrian Merlo, Jean-Louis BoulayJournal of Neuro-Oncology|November 19, 2016
Reverse phase protein arrays enable glioblastoma molecular subtypingGregor Hutter, Martin Sailer, Tej Deepak Azad, et al.Pageof 9